Wilson WH, Phillips T, Popplewell L, de Vos S, et al. Phase 1b/2 study of ibrutinib and lenalidomide with dose-adjusted EPOCH-R in patients with relapsed/refractory diffuse large B-cell lymphoma. Leuk Lymphoma 2021 Apr 15:1-16. doi: 10.1080/10428194.2021.1907371.
PMID: 33856277